When Japanese Witnesses Testify in U.S. Courts: Answers to Nine Common Concerns

On November 19, Axinn partner Matthew Murphy will speak on the "Understanding IP Exclusivity Rights Considering the Latest Antitrust Landscape" panel at Kisaco Research's Pharma & Biotech Patent Litigation Summit, being held November 18-19 in Philadelphia. 

Axinn partners Lisl Dunlop, Bradley Justus, and James Hunsberger, along with associate Aigerim Saudabayeva, authored the global introduction and the U.S. chapter titled, “United States: Enforcement Agencies Display Openness to Negotiating and Accepting Remedies Amid HSR Growing Pains” for Global Competition Review's Market Review: Merger Control 2025.As part of a comprehensive review of the past year in U.S. merger control, the chapter examines how, even as the new HSR rules introduce challenges, the DOJ and FTC have shown greater openness to negotiating and accepting remedies—creating a more predictable, business-friendly environment for dealmaking. It also highlights key enforcement trends, the growing role of state-level review, and practical advice to get deals cleared quickly.